Evotec
Luigi D'Innocenti is a finance professional with extensive experience in consolidation, reporting, and financial analysis, currently serving as Junior Manager of Group Consolidation and Reporting at Evotec since October 2024. Prior to this role, Luigi held leadership positions at BASF, where responsibilities included team stabilization and intercompany reconciliation processes, along with earlier roles as Senior Accountant. Luigi's career began at Johnson & Johnson, progressing through financial planning at MSD, and payroll management at ADP. Luigi holds multiple qualifications in management accounting from CIMA and a Master's degree in Corporate Finance from Università degli Studi Roma Tre.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.